Bio-Techne Corp (TECH) concluded trading on Thursday at a closing price of $49.78, with 4.41 million shares of worth about $219.34 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.41% during that period and on May 08, 2025 the price saw a gain of about 2.11%. Currently the company’s common shares owned by public are about 158.09M shares, out of which, 156.31M shares are available for trading.
Stock saw a price change of 0.30% in past 5 days and over the past one month there was a price change of 1.99%. Year-to-date (YTD), TECH shares are showing a performance of -30.89% which decreased to -34.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $46.01 but also hit the highest price of $85.57 during that period. The average intraday trading volume for Bio-Techne Corp shares is 2.05 million. The stock is currently trading -0.11% below its 20-day simple moving average (SMA20), while that difference is down -10.37% for SMA50 and it goes to -28.01% lower than SMA200.
Bio-Techne Corp (NASDAQ: TECH) currently have 158.09M outstanding shares and institutions hold larger chunk of about 100.46% of that.
The stock has a current market capitalization of $7.87B and its 3Y-monthly beta is at 1.42. PE ratio of stock for trailing 12 months is 60.83, while it has posted earnings per share of $0.82 in the same period. Its PEG reads 5.29 and has Quick Ratio of 2.58 while making debt-to-equity ratio of 0.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TECH, volatility over the week remained 5.03% while standing at 5.19% over the month.
Analysts are in expectations that Bio-Techne Corp (TECH) stock would likely to be making an EPS of 0.52 in the current quarter, while forecast for next quarter EPS is 0.45 and it is 2.11 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.48 which is 0.56 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.49 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 7.46% while it is estimated to increase by 10.53% in next year. EPS is likely to grow at an annualized rate of 11.50% for next 5-years, compared to annual growth of 11.13% made by the stock over the past 5-years.
Coverage by Evercore ISI stated Bio-Techne Corp (TECH) stock as an Outperform in their note to investors on March 18, 2025, suggesting a price target of $75 for the stock. On February 19, 2025, Robert W. Baird Downgrade their recommendations, while on May 22, 2024, Citigroup Downgrade their ratings for the stock with a price target of $85. Stock get a Sector outperform rating from Scotiabank on February 08, 2024.
